0001179110-20-004529.txt : 20200402
0001179110-20-004529.hdr.sgml : 20200402
20200402171721
ACCESSION NUMBER: 0001179110-20-004529
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200331
FILED AS OF DATE: 20200402
DATE AS OF CHANGE: 20200402
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dreier Ashley
CENTRAL INDEX KEY: 0001614957
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36568
FILM NUMBER: 20770180
MAIL ADDRESS:
STREET 1: 15 W. SCENIC POINTE DR., STE. 100
CITY: DRAPER
STATE: UT
ZIP: 84020
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HEALTHEQUITY, INC.
CENTRAL INDEX KEY: 0001428336
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0131
BUSINESS ADDRESS:
STREET 1: 15 WEST SCENIC POINTE DRIVE
STREET 2: SUITE 100
CITY: DRAPER
STATE: UT
ZIP: 84020
BUSINESS PHONE: 801-727-1000
MAIL ADDRESS:
STREET 1: 15 WEST SCENIC POINTE DRIVE
STREET 2: SUITE 100
CITY: DRAPER
STATE: UT
ZIP: 84020
FORMER COMPANY:
FORMER CONFORMED NAME: HEALTHEQUITY INC
DATE OF NAME CHANGE: 20080227
4
1
edgar.xml
FORM 4 -
X0306
4
2020-03-31
0
0001428336
HEALTHEQUITY, INC.
HQY
0001614957
Dreier Ashley
C/O HEALTHEQUITY, INC.
15 W. SCENIC POINTE DR., STE. 100
DRAPER
UT
84020
0
1
0
0
Executive, VP, CTO and CIO
Common Stock
2020-03-31
4
A
0
6121
0
A
34913
D
Common Stock
2020-03-31
4
A
0
4528
0
A
39441
D
Common Stock
2020-03-31
4
A
0
13351
0
A
52792
D
Stock Option (right to buy)
24.36
2026-03-23
Common Stock
16250
16250
D
Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest as to 6,121 shares on the date of the meeting of the Company's compensation committee to be held in the first quarter of the fiscal year ended January 31, 2022.
Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest as to 4,528 shares on the date of the meeting of the Company's compensation committee to be held in the first quarter of the fiscal year ended January 31, 2023.
The option is immediately exercisable.
/s/ Ashley Dreier
2020-04-02